Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Thomas Smith's Stock Ratings
Leerink Partners Analyst
Thomas Smith is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/06/2025
Overall Average Return
-%
Smart Score
Overall Average Return Percentile
-
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/28/2025 | EQ | Buy Now | Equillium | $0.41 | 140.96% | Thomas Smith33% | $3 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/11/2024 | QTTB | Buy Now | Q32 Bio | $1.50 | 500% | Thomas Smith33% | $68 → $9 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/19/2024 | ACRS | Buy Now | Aclaris Therapeutics | $1.27 | 451.18% | Thomas Smith33% | $2 → $7 | Upgrade | Market Perform → Outperform | Get Alert |
| 07/23/2024 | ALMS | Buy Now | Alumis | $4.80 | 504.17% | Thomas Smith33% | → $29 | Initiates | → Outperform | Get Alert |
| 05/21/2024 | QTTB | Buy Now | Q32 Bio | $1.50 | 3500% | Thomas Smith33% | → $54 | Initiates | → Outperform | Get Alert |
| 04/23/2024 | RNAC | Buy Now | Cartesian Therapeutics | $12.44 | 213.5% | Thomas Smith33% | → $39 | Initiates | → Outperform | Get Alert |
| 04/12/2024 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Thomas Smith33% | $42 → $65 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/25/2024 | SGMT | Buy Now | Sagimet Biosciences | $3.75 | 594.15% | Thomas Smith33% | → $26 | Initiates | → Outperform | Get Alert |
| 02/21/2024 | RAPT | Buy Now | RAPT Therapeutics | $0.92 | 991.35% | Thomas Smith33% | → $10 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/20/2024 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Thomas Smith33% | → $32.5 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/14/2023 | ABVX | Buy Now | Abivax | $7.13 | 180.5% | Thomas Smith33% | → $20 | Initiates | → Outperform | Get Alert |
| 05/23/2023 | VECT | Buy Now | VectivBio Holding | — | — | Thomas Smith33% | $30 → $17 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/08/2023 | MORF | Buy Now | Morphic Holding | — | — | Thomas Smith33% | $45 → $56 | Maintains | Outperform | Get Alert |
| 03/03/2023 | ARGX | Buy Now | argenx | $656.65 | -33.75% | Thomas Smith33% | $430 → $435 | Maintains | Outperform | Get Alert |
| 03/03/2023 | ICPT | Buy Now | Intercept Pharma | — | — | Thomas Smith33% | $17 → $18 | Maintains | Market Perform | Get Alert |
| 02/28/2023 | IRON | Buy Now | Disc Medicine | $48.60 | -25.93% | Thomas Smith33% | → $36 | Initiates | → Outperform | Get Alert |
| 02/08/2023 | EQ | Buy Now | Equillium | $0.41 | 1586.75% | Thomas Smith33% | $12 → $7 | Maintains | Outperform | Get Alert |
| 02/08/2023 | CNTB | Buy Now | Connect Biopharma Hldgs | $0.79 | 786.08% | Thomas Smith33% | $9 → $7 | Maintains | Outperform | Get Alert |
| 02/08/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | Thomas Smith33% | $10 → $12 | Maintains | Outperform | Get Alert |
| 02/06/2023 | IMVT | Buy Now | Immunovant | $15.11 | 38.98% | Thomas Smith33% | $14 → $21 | Maintains | Outperform | Get Alert |
| 01/09/2023 | VRDN | Buy Now | Viridian Therapeutics | $13.12 | 242.99% | Thomas Smith33% | $40 → $45 | Maintains | Outperform | Get Alert |
| 11/22/2022 | TRVI | Buy Now | Trevi Therapeutics | $6.78 | -11.5% | Thomas Smith33% | → $6 | Initiates | → Outperform | Get Alert |
| 11/21/2022 | ALPN | Buy Now | Alpine Immune Sciences | — | — | Thomas Smith33% | → $16 | Initiates | → Outperform | Get Alert |
| 11/21/2022 | PRVB | Buy Now | Provention Bio | — | — | Thomas Smith33% | $16 → $19 | Maintains | Outperform | Get Alert |
| 11/11/2022 | LABP | Buy Now | Landos Biopharma | — | — | Thomas Smith33% | $3 → $2 | Maintains | Market Perform | Get Alert |
| 11/09/2022 | MNKD | Buy Now | MannKind | $4.95 | 21.21% | Thomas Smith33% | $5 → $6 | Maintains | Outperform | Get Alert |
| 10/28/2022 | ARGX | Buy Now | argenx | $656.65 | -34.52% | Thomas Smith33% | $428 → $430 | Maintains | Outperform | Get Alert |
| 10/21/2022 | IMUX | Buy Now | Immunic | $1.11 | 350.13% | Thomas Smith33% | $9 → $5 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/13/2022 | VECT | Buy Now | VectivBio Holding | — | — | Thomas Smith33% | $28 → $30 | Maintains | Outperform | Get Alert |
| 10/11/2022 | DICE | Buy Now | DICE Therapeutics | — | — | Thomas Smith33% | $46 → $77 | Maintains | Outperform | Get Alert |
| 10/03/2022 | ICPT | Buy Now | Intercept Pharma | — | — | Thomas Smith33% | $21 → $17 | Maintains | Market Perform | Get Alert |
| 09/08/2022 | EQ | Buy Now | Equillium | $0.41 | 2791.57% | Thomas Smith33% | $14 → $12 | Maintains | Outperform | Get Alert |
| 08/25/2022 | MLTX | Buy Now | MoonLake | $41.91 | -59.43% | Thomas Smith33% | → $17 | Initiates | → Outperform | Get Alert |
| 08/12/2022 | LABP | Buy Now | Landos Biopharma | — | — | Thomas Smith33% | $16 → $3 | Maintains | Market Perform | Get Alert |
| 08/12/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Thomas Smith33% | $55 → $60 | Maintains | Outperform | Get Alert |
| 08/09/2022 | CLDX | Buy Now | Celldex Therapeutics | $19.53 | 227.72% | Thomas Smith33% | $68 → $64 | Maintains | Outperform | Get Alert |
| 08/09/2022 | PRTC | Buy Now | PureTech Health | $17.45 | 301.15% | Thomas Smith33% | $66 → $70 | Maintains | Outperform | Get Alert |
| 08/03/2022 | AXLA | Buy Now | Axcella Health | — | — | Thomas Smith33% | $9 → $6 | Maintains | Outperform | Get Alert |
| 07/29/2022 | ARGX | Buy Now | argenx | $656.65 | -34.82% | Thomas Smith33% | $404 → $428 | Maintains | Outperform | Get Alert |
| 07/11/2022 | ETNB | Buy Now | 89bio | $8.61 | 236.82% | Thomas Smith33% | $50 → $29 | Maintains | Outperform | Get Alert |
| 07/08/2022 | ICPT | Buy Now | Intercept Pharma | — | — | Thomas Smith33% | $27 → $21 | Maintains | Market Perform | Get Alert |
| 06/15/2022 | PRTC | Buy Now | PureTech Health | $17.45 | 278.22% | Thomas Smith33% | $70 → $66 | Maintains | Outperform | Get Alert |
| 06/03/2022 | IMUX | Buy Now | Immunic | $1.11 | 710.23% | Thomas Smith33% | $45 → $9 | Maintains | Outperform | Get Alert |
| 06/01/2022 | ELDN | Buy Now | Eledon Pharma | $3.30 | 687.88% | Thomas Smith33% | $33 → $26 | Maintains | Outperform | Get Alert |
| 05/12/2022 | ALLK | Buy Now | Allakos | $0.33 | 3579.85% | Thomas Smith33% | $13 → $12 | Maintains | Market Perform | Get Alert |
| 05/04/2022 | CNTB | Buy Now | Connect Biopharma Hldgs | $0.79 | 1039.24% | Thomas Smith33% | $22 → $9 | Maintains | Outperform | Get Alert |
| 04/28/2022 | VKTX | Buy Now | Viking Therapeutics | $29.49 | -59.31% | Thomas Smith33% | $18 → $12 | Maintains | Outperform | Get Alert |
| 04/11/2022 | GNFT | Buy Now | Genfit | $4.68 | 113.68% | Thomas Smith33% | $15 → $10 | Maintains | Outperform | Get Alert |
| 03/31/2022 | AXLA | Buy Now | Axcella Health | — | — | Thomas Smith33% | $10 → $9 | Maintains | Outperform | Get Alert |
| 03/25/2022 | ETNB | Buy Now | 89bio | $8.61 | 480.72% | Thomas Smith33% | $62 → $50 | Maintains | Outperform | Get Alert |
| 03/10/2022 | RXDX | Buy Now | Prometheus Biosciences | — | — | Thomas Smith33% | $47 → $55 | Maintains | Outperform | Get Alert |
| 03/03/2022 | ICPT | Buy Now | Intercept Pharma | — | — | Thomas Smith33% | $30 → $27 | Maintains | Market Perform | Get Alert |
| 02/16/2022 | ALLK | Buy Now | Allakos | $0.33 | 3886.51% | Thomas Smith33% | $17 → $13 | Maintains | Market Perform | Get Alert |
| 01/07/2022 | PRTC | Buy Now | PureTech Health | $17.45 | 301.15% | Thomas Smith33% | $76 → $70 | Maintains | Outperform | Get Alert |
| 01/06/2022 | CNTB | Buy Now | Connect Biopharma Hldgs | $0.79 | 2684.81% | Thomas Smith33% | $32 → $22 | Maintains | Outperform | Get Alert |
| 01/05/2022 | EQ | Buy Now | Equillium | $0.41 | 3273.49% | Thomas Smith33% | $18 → $14 | Maintains | Outperform | Get Alert |
| 12/22/2021 | ALLK | Buy Now | Allakos | $0.33 | 5113.12% | Thomas Smith33% | $150 → $17 | Downgrade | Outperform → Market Perform | Get Alert |
| 12/08/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Thomas Smith33% | $43 → $47 | Maintains | Outperform | Get Alert |
| 11/18/2021 | VRDN | Buy Now | Viridian Therapeutics | $13.12 | 143.9% | Thomas Smith33% | → $32 | Initiates | → Outperform | Get Alert |
| 11/16/2021 | LABP | Buy Now | Landos Biopharma | — | — | Thomas Smith33% | $20 → $16 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/15/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Thomas Smith33% | $34 → $43 | Maintains | Outperform | Get Alert |
| 09/10/2021 | CLDX | Buy Now | Celldex Therapeutics | $19.53 | 248.2% | Thomas Smith33% | → $68 | Initiates | → Outperform | Get Alert |
| 08/25/2021 | PRTC | Buy Now | PureTech Health | $17.45 | 335.53% | Thomas Smith33% | $74 → $76 | Maintains | Outperform | Get Alert |
| 08/12/2021 | RAPT | Buy Now | RAPT Therapeutics | $0.92 | 5247.59% | Thomas Smith33% | → $49 | Initiates | → Outperform | Get Alert |
| 06/02/2021 | IMVT | Buy Now | Immunovant | $15.11 | 12.51% | Thomas Smith33% | $38 → $17 | Maintains | Outperform | Get Alert |
| 05/04/2021 | VECT | Buy Now | VectivBio Holding | — | — | Thomas Smith33% | → $28 | Initiates | → Outperform | Get Alert |
| 04/27/2021 | ELDN | Buy Now | Eledon Pharma | $3.30 | 900% | Thomas Smith33% | $34 → $33 | Maintains | Outperform | Get Alert |
| 04/13/2021 | CNTB | Buy Now | Connect Biopharma Hldgs | $0.79 | 3950.63% | Thomas Smith33% | → $32 | Initiates | → Outperform | Get Alert |
| 04/09/2021 | PRVB | Buy Now | Provention Bio | — | — | Thomas Smith33% | $26 → $16 | Maintains | Outperform | Get Alert |
| 04/06/2021 | RXDX | Buy Now | Prometheus Biosciences | — | — | Thomas Smith33% | → $34 | Initiates | → Outperform | Get Alert |
| 04/05/2021 | GNFT | Buy Now | Genfit | $4.68 | 220.51% | Thomas Smith33% | $20 → $15 | Maintains | Outperform | Get Alert |
| 03/23/2021 | ETNB | Buy Now | 89bio | $8.61 | 620.09% | Thomas Smith33% | $56 → $62 | Maintains | Outperform | Get Alert |
| 03/16/2021 | GLTO | Buy Now | Galecto | $2.90 | 451.72% | Thomas Smith33% | $27 → $16 | Maintains | Outperform | Get Alert |
| 03/05/2021 | MNKD | Buy Now | MannKind | $4.95 | 1.01% | Thomas Smith33% | $3 → $5 | Maintains | Outperform | Get Alert |
| 03/04/2021 | ACRS | Buy Now | Aclaris Therapeutics | $1.27 | 1947.24% | Thomas Smith33% | $21 → $26 | Maintains | Outperform | Get Alert |
| 03/01/2021 | LABP | Buy Now | Landos Biopharma | — | — | Thomas Smith33% | → $20 | Initiates | → Outperform | Get Alert |
| 02/08/2021 | ELDN | Buy Now | Eledon Pharma | $3.30 | 930.3% | Thomas Smith33% | → $34 | Initiates | → Outperform | Get Alert |
| 02/03/2021 | IMVT | Buy Now | Immunovant | $15.11 | 151.49% | Thomas Smith33% | $52 → $38 | Maintains | Outperform | Get Alert |
| 01/20/2021 | ACRS | Buy Now | Aclaris Therapeutics | $1.27 | 1553.54% | Thomas Smith33% | $4.5 → $21 | Maintains | Outperform | Get Alert |
| 01/15/2021 | PRTC | Buy Now | PureTech Health | $17.45 | 301.15% | Thomas Smith33% | → $70 | Initiates | → Outperform | Get Alert |
| 12/21/2020 | ALLK | Buy Now | Allakos | $0.33 | 45898.16% | Thomas Smith33% | → $150 | Initiates | → Outperform | Get Alert |
| 12/08/2020 | KROS | Buy Now | Keros Therapeutics | $14.23 | 462.19% | Thomas Smith33% | $42 → $80 | Maintains | Outperform | Get Alert |
| 11/23/2020 | GLTO | Buy Now | Galecto | $2.90 | 831.03% | Thomas Smith33% | → $27 | Initiates | → Outperform | Get Alert |
| 11/13/2020 | IMVT | Buy Now | Immunovant | $15.11 | 244.14% | Thomas Smith33% | $39 → $52 | Maintains | Outperform | Get Alert |
| 11/11/2020 | ETNB | Buy Now | 89bio | $8.61 | 550.41% | Thomas Smith33% | $51 → $56 | Maintains | Outperform | Get Alert |
| 11/10/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Thomas Smith33% | $50 → $48 | Maintains | Market Perform | Get Alert |
| 10/26/2020 | AXLA | Buy Now | Axcella Health | — | — | Thomas Smith33% | → $10 | Assumes | → Outperform | Get Alert |
| 10/02/2020 | IMUX | Buy Now | Immunic | $1.11 | 3951.13% | Thomas Smith33% | → $45 | Initiates | → Outperform | Get Alert |
| 08/20/2020 | IMVT | Buy Now | Immunovant | $15.11 | 125.02% | Thomas Smith33% | $26 → $34 | Maintains | Outperform | Get Alert |
| 08/06/2020 | AXLA | Buy Now | Axcella Health | — | — | Thomas Smith33% | $20 → $10 | Maintains | Outperform | Get Alert |
| 06/30/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Thomas Smith33% | $89 → $50 | Maintains | Market Perform | Get Alert |
| 05/18/2020 | AXLA | Buy Now | Axcella Health | — | — | Thomas Smith33% | $21 → $20 | Maintains | Outperform | Get Alert |
| 05/12/2020 | GNFT | Buy Now | Genfit | $4.68 | 327.35% | Thomas Smith33% | $50 → $20 | Maintains | Outperform | Get Alert |
| 05/04/2020 | KROS | Buy Now | Keros Therapeutics | $14.23 | 195.15% | Thomas Smith33% | → $42 | Initiates | → Outperform | Get Alert |
| 02/24/2020 | IMVT | Buy Now | Immunovant | $15.11 | 58.84% | Thomas Smith33% | → $24 | Initiates | → Outperform | Get Alert |
| 02/21/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Thomas Smith33% | — | Upgrade | Underperform → Market Perform | Get Alert |
| 12/09/2019 | ETNB | Buy Now | 89bio | $8.61 | 538.79% | Thomas Smith33% | → $55 | Initiates | → Outperform | Get Alert |
| 10/23/2019 | ACRS | Buy Now | Aclaris Therapeutics | $1.27 | — | Thomas Smith33% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 10/22/2019 | ACRS | Buy Now | Aclaris Therapeutics | $1.27 | — | Thomas Smith33% | — | Upgrade | Market Perform → Outperform | Get Alert |
| 06/27/2019 | ACRS | Buy Now | Aclaris Therapeutics | $1.27 | — | Thomas Smith33% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/06/2019 | ACRS | Buy Now | Aclaris Therapeutics | $1.27 | — | Thomas Smith33% | — | Initiates | → Outperform | Get Alert |
| 04/24/2019 | GNFT | Buy Now | Genfit | $4.68 | 1139.32% | Thomas Smith33% | → $58 | Initiates | → Outperform | Get Alert |
| 03/29/2019 | VKTX | Buy Now | Viking Therapeutics | $29.49 | — | Thomas Smith33% | — | Upgrade | Market Perform → Outperform | Get Alert |
